Ephedra Supplement Safety To Be Revisited At Senate Subcommittee Hearing
This article was originally published in The Tan Sheet
Executive Summary
An "independent analysis" of 14,700 ephedra-related adverse event reports received by Metabolife International will be discussed by the Senate Governmental Affairs/Oversight of Government Management Subcommittee during a hearing slated for Oct. 8